The Latest Cardiac and Vascular News
SANTA CLARA, Calif., March 14, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its board of directors has authorized a $20.0 million stock repurchase program. Semler Scientific may purchase shares on a discretionary basis from time […]
Topline data from Phase 2b ASPEN-COVID-19 clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 anticipated in the last week of March 2022 WESTMINSTER, Colo., March 14, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular […]
Decorated physician brings 30+ years of experience to patients on Cape Cod HYANNIS, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Harold J. Welch, MD, FACS, RVT, RPVI has recently joined the Hyannis, […]
SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022. Mr. King joined the iRhythm Board in […]
ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced the appointment of Martin B. Leon, M.D. as Executive Chair of the U.S. early feasibility study […]
PARIS, March 14, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announces that Stéphane Cohen, a pharmacist and ESSEC graduate, is joining the team as Director […]
Significant Progress Anticipated in 2022 with Initiation of Clinical Trial for VERVE-101 and IND-enabling Studies for ANGPTL3 Program Presentations at Upcoming Scientific Conferences to Highlight Novel Base Editing Approach and Proprietary Lipid Nanoparticle Delivery System Cash, Cash Equivalents and Marketable Securities of $360.4 Million with Cash Runway into 2024 CAMBRIDGE, Mass., […]
Forms Growth Capital Partnership to Support Expansion LAS VEGAS–(BUSINESS WIRE)–Nevada Heart and Vascular Centers, L.L.P. (“Nevada Heart & Vascular”, “NHV” or the “Company”), a leading provider of cardiac and vascular services in Southern-Nevada, announced today that it has appointed proven healthcare leader David Stillwell to serve as Chief Operating Officer […]
IRVINE, Calif., March 10, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the commencement of an underwritten public offering of 2,000,000 shares of its common stock. […]
VANCOUVER and MINNEAPOLIS, March 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2021. Highlights Achieved record revenue in Q4 of $759,000, an increase of 48% over the same period in […]
